Listen to this episode

What the filing says

A summary of management's own discussion and analysis from the filing.

MD&A Summary: Lockheed Martin Corporation (Q3 2026 Filing)

> Note: Despite the SEC filing format referencing airline MD&A, this document is from Lockheed Martin, a global aerospace and defense company, not an airline. The summary below reflects the actual content.

---

1. Key Performance Drivers

  • Sales growth driven by production ramp-ups across all four segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space
  • Primary drivers include the F-35, PAC-3, THAAD, GMLRS, PrSM, C-130, and F-22 programs
  • 70% of $58.8B in nine-month sales derived from U.S. Government (61% from Department of Defense)
  • New multi-year contracts signed in 2026 for PAC-3 MSE, THAAD, PrSM, JATM, and F-35 sustainment

---

2. Capacity and Demand Trends

  • Global security tensions (Middle East, Europe, Pacific) are driving demand for defense products
  • U.S. Government focused on increasing industry production capacity for long-term demand
  • FY2026 defense appropriations totaled $839.2B, up $8.4B over the budget request
  • FY2027 proposed defense budget represents a historic $1.5 trillion request, emphasizing munitions, Golden Dome missile defense, and expanded F-35 procurement
  • A continuing resolution maintains FY2026 funding levels through December 11, 2026; full-year FY2027 appropriations remain uncertain

---

3. Revenue and Margin Commentary

  • Q3 2026 product sales increased $2.1B (+14%) year-over-year, led by MFC (+$865M), Aeronautics (+$845M), Space (+$225M), and RMS (+$185M)
  • Nine-month product sales increased $3.6B (+8%), led by MFC (+$1.8B) and Aeronautics (+$1.3B)
  • Nine-month service sales increased $421M (+5%), driven by F-35 sustainment and RMS
  • Net earnings rose to $1.8B ($7.97/share) in Q3 2026, versus $1.6B ($6.95/share) in Q3 2025
  • Nine-month net earnings of $5.2B ($22.36/share) versus $3.7B ($15.69/share) in the prior year period
  • Unfavorable profit adjustments recorded in 2026: F-16 (-$170M), C-130 (-$175M), Heavy Lift (-$125M), Seahawk (-$95M)
  • Effective tax rate declined to 15.6% for the nine months ended September 2026, down from 16.4% in the prior year period

---

4. Cost Factors

  • Supply chain disruptions remain an ongoing challenge, including supplier shortages and performance issues
  • Inflationary pressures continue to present risks, particularly for existing fixed-price contracts
  • Tariffs may impact material and component costs; however, management does not expect existing tariffs to have a material long-term impact; approximately $225M in tariff refunds received through Q3 2026
  • Rare earth mineral supply is an emerging risk; management is pursuing alternative sourcing and long-term supply agreements
  • Product costs increased $1.9B (+14%) in Q3 2026, consistent with higher production volumes

---

5. Forward-Looking Statements

  • Management expects supply chain pressures, inflation, and tariffs could adversely affect future profits, margins, and cash flows, particularly on fixed-price contracts
  • The FY2027 budget and appropriations outcome remains uncertain; shifting funding priorities could materially impact programs
  • The company is no longer subject to CAMT in 2026 and expects reduced federal income tax payments following the One Big Beautiful Bill Act
  • Management acknowledged risk of additional losses on certain programs in Aeronautics, MFC, and RMS segments

-

Full transcript

The complete episode in text. Prefer reading to listening — this is the same analysis, word for word.

Sarah: Lockheed Martin just posted twenty point seven billion dollars in quarterly revenue — an eleven percent jump year-over-year — while simultaneously absorbing nearly half a billion dollars in unfavorable profit adjustments on programs including the F-16, the C-130, and the Seahawk helicopter.

Mike: That's the tension that runs through this entire filing. The top line is accelerating hard, driven by a genuine production ramp across every segment, but the cost structure underneath it is showing stress fractures on fixed-price contracts. And that gap between revenue growth and operating income growth is where the real story lives.

Sarah: This is straight out of the ten-Q Lockheed filed on October twenty-second, covering the quarter ended September twenty-seventh, twenty twenty-six. If you want same-week reads on filings like this one, follow the show.

Mike: If we reduce this filing to one sentence, it's this: Lockheed Martin is executing a government-mandated production surge that is growing revenue faster than it is growing profit, and the fixed-price contract book is the fault line that could determine whether this expansion creates durable value or destroys it. Based on this filing, Lockheed Martin is operating in mid-cycle expansion — volume is rising, new multi-year contracts are being signed across every major platform, and the budget environment is the most favorable it has been in a generation. But mid-cycle expansion for a defense prime is not the same as smooth sailing. The execution risk embedded in fixed-price development work is a real and present constraint on how much of that revenue growth actually flows to shareholders.

Sarah: Let's get into the numbers. Revenue came in at twenty point seven one billion dollars for the quarter, up eleven point three percent compared to the same quarter in twenty twenty-five, when Lockheed posted eighteen point six one billion. Operating income reached two point four four billion, up seven point one percent year-over-year from two point two eight billion. Net income was one point eight four billion, up fourteen percent from one point six two billion in the prior year quarter. And earnings per share came in at seven dollars and ninety-seven cents, up fourteen point seven percent from six dollars and ninety-five cents a year ago.

Mike: Here is what those numbers tell you when you put them in context. Revenue grew at eleven percent. Operating income grew at only seven percent. That divergence — revenue outpacing operating income — is the signature of a company absorbing cost headwinds even as volume surges. For a defense prime of Lockheed's scale, operating margins in the eleven to thirteen percent range are historically normal. When revenue is growing faster than operating income, that margin is compressing, not expanding. The filing is explicit about why. Management disclosed unfavorable profit adjustments totaling approximately five hundred sixty-five million dollars across four programs: negative one hundred seventy million on the F-16, negative one hundred seventy-five million on the C-130, negative one hundred twenty-five million on the Heavy Lift program, and negative ninety-five million on the Seahawk. Those are not rounding errors. That is a material drag on what would otherwise be a very strong quarter.

Sarah: And the EPS growth of nearly fifteen percent outpacing operating income growth of seven percent — what explains that spread?

Mike: Two things. First, the effective tax rate declined to fifteen point six percent for the nine months ended September twenty twenty-six, down from sixteen point four percent in the comparable prior year period. The filing notes that Lockheed is no longer subject to the Corporate Alternative Minimum Tax in twenty twenty-six, and that the One Big Beautiful Bill Act, signed into law on July fourth, twenty twenty-five, is expected to reduce federal income tax payments going forward. Second, the share count is lower, which mechanically amplifies per-share figures. So the EPS story is partly real earnings growth and partly tax and capital structure tailwinds. Investors should be careful not to read the fourteen point seven percent EPS growth as a direct proxy for operational improvement.

Sarah: Let's turn to what management actually said in the MD&A, because the language in this filing is worth examining closely. What stood out to you?

Mike: Several things. On the demand side, management was notably direct about the geopolitical backdrop. The filing states that conflicts and tensions in the Middle East, Europe, and the Pacific region have, quote, "heightened tensions and highlighted security requirements globally." They are not hedging that language. They are connecting it explicitly to new multi-year contracts signed in twenty twenty-six for PAC-3 MSE, THAAD, the Precision Strike Missile, the Joint Advanced Tactical Missile, and an F-35 sustainment framework. That is a meaningful list of long-cycle commitments being locked in simultaneously.

Sarah: And on the cost side?

Mike: Management was candid about the ongoing pressure. The filing states, and I am quoting directly here, that the company continues to "experience supply chain challenges, including supplier shortages and performance issues." They also note that "although on-time deliveries have generally been steady, pressures remain in certain areas." That is careful language — they are not declaring a crisis, but they are not dismissing the risk either. On tariffs, management said they "do not currently expect existing tariffs to have a material long-term impact on our results of operations," and they disclosed approximately two hundred twenty-five million dollars in tariff refunds received through the third quarter of twenty twenty-six. That refund is a one-time cash benefit, not a recurring tailwind.

Sarah: The rare earth mineral language was new to me. How significant is that?

Mike: It is worth flagging. The filing introduces specific language around rare earth minerals, noting that "recent government actions relating to rare earth minerals that are used in certain of our products have raised concerns about supply availability." Management says they are monitoring the situation, pursuing alternative sources, and securing supply through long-term agreements. The tone is measured, but the fact that it appears explicitly in the MD&A means management felt it warranted disclosure. For a company building precision munitions and advanced fighter aircraft, rare earth dependency is not a trivial operational footnote.

Sarah: Let's move to financial red flags and confirmations. From a balance sheet standpoint, what is the picture?

Mike: There are genuine confirmations here alongside a few items that deserve scrutiny. Cash and equivalents came in at five point nine six billion dollars, up seventy-one point eight percent compared to the same quarter a year ago, when cash stood at three point four seven billion. That is a substantial improvement in the liquidity position. Stockholders' equity reached ten point zero six billion, up sixty-two point eight percent year-over-year from six point one eight billion. Total assets grew to sixty-four point five one billion, up seven percent from sixty point two eight billion. On the surface, the balance sheet is strengthening.

Sarah: But there is a long-term debt figure that needs context.

Mike: Correct. Long-term debt stands at twenty point five zero billion dollars. To put that in perspective, that is roughly three and a half times the cash on hand, and it represents a significant leverage load for a company whose operating income for a single quarter was two point four four billion. Defense primes historically carry meaningful debt loads because their revenue base is stable and government-backed, which supports leverage. But the ratio of long-term debt to cash — approximately three point four to one — is a number worth watching, particularly if the budget environment becomes less favorable. The causality chain here is straightforward: if Congressional appropriations for twenty twenty-seven come in materially below the administration's historic one point five trillion dollar request, program volumes could slow, cash generation could compress, and that debt load becomes a more acute constraint. The filing is explicit that full-year twenty twenty-seven appropriations remain uncertain, and that a continuing resolution signed September second, twenty twenty-six, maintains twenty twenty-six funding levels only through December eleventh, twenty twenty-six.

Sarah: That continuing resolution is a real operational constraint, isn't it?

Mike: It is. Under a continuing resolution, new program starts are generally blocked. Existing programs continue at prior-year funding rates, but the administration's ambitious twenty twenty-seven budget — which emphasizes a seven hundred sixty billion dollar weapons procurement and modernization effort, Golden Dome missile defense, and increased F-35 purchases — cannot be fully executed until full-year appropriations are enacted. Management acknowledged this directly, noting that "the timing and ultimate level of FY 2027 defense funding remain uncertain." That is not boilerplate. That is a genuine near-term constraint on new contract awards.

Sarah: Let's talk about risk disclosures. The filing notes no new or significantly escalated risk factors compared to the prior filing. But the MD&A itself surfaces several risks worth naming explicitly.

Mike: The primary risks cluster around three themes. First, fixed-price contract exposure. Management explicitly warned that supply chain issues and high rates of inflation, if unmitigated, could adversely affect "future profits, margins and cash flows, particularly for existing fixed-price contracts." The five hundred sixty-five million dollars in unfavorable adjustments this quarter is evidence that this risk is not theoretical — it is already materializing. Second, the rare earth mineral supply chain, which we discussed. Third, the budget and policy environment. The filing notes that the administration "continues to take steps to evaluate government-wide and defense-specific staffing and procurement," and that those actions "remain uncertain and could result in impacts to both our current and future business prospects." That is unusually direct language about procurement policy risk from a company that derives seventy percent of its revenue from the U.S. Government.

Sarah: From a liquidity and balance sheet stress standpoint, let's go deeper. The cash position improved dramatically. What is driving that?

Mike: The filing does not break out the precise drivers of the cash increase in the excerpt we have, but the directional story is clear. Nine-month net earnings of five point two billion dollars, compared to three point seven billion in the prior year period, represent a substantial improvement in earnings generation. The tax tailwinds we discussed — the elimination of the Corporate Alternative Minimum Tax and the One Big Beautiful Bill Act provisions — are also reducing cash outflows. The two hundred twenty-five million in tariff refunds is a smaller but real contributor. What the filing does not explicitly address in the available excerpt is working capital dynamics and free cash flow conversion. For a defense prime, that distinction matters enormously. Earnings are accrual-based, recognized on a percentage-of-completion basis. The real test is whether those earnings are converting to actual cash. The seventy-one point eight percent year-over-year increase in cash and equivalents is encouraging, but investors should track free cash flow conversion against net income when the full-year results are available.

Sarah: Let's go segment by segment. Which segments are carrying the load and which are showing stress?

Mike: The quarter's revenue growth was broad-based, but the composition is telling. Missiles and Fire Control was the single largest contributor to product sales growth in the quarter, adding approximately eight hundred sixty-five million dollars in incremental revenue, driven by production ramp-ups on PAC-3, THAAD, GMLRS, and the Precision Strike Missile. That is the segment most directly tied to the global munitions demand surge, and it is performing accordingly. Aeronautics added approximately eight hundred forty-five million dollars, driven by higher volume on F-35 and C-130 production contracts. Space contributed approximately two hundred twenty-five million in incremental product sales, led by the Fleet Ballistic Missile and Next Generation Interceptor programs, partially offset by program lifecycle on the OPIR mission. Rotary and Mission Systems added approximately one hundred eighty-five million, driven by radar programs.

Sarah: But the profit adjustments were concentrated in Aeronautics and RMS.

Mike: Exactly. The F-16 negative one hundred seventy million and the C-130 negative one hundred seventy-five million sit in Aeronautics. The Seahawk negative ninety-five million sits in Rotary and Mission Systems. The Heavy Lift negative one hundred twenty-five million also falls in that segment family. So the segment that is generating the most revenue growth — Aeronautics — is also absorbing the largest unfavorable adjustments. That is the structural tension in this filing. MFC is the clean growth story. Aeronautics is the complicated one. Management acknowledged the risk of additional losses on certain programs in Aeronautics, MFC, and RMS segments, which means these adjustments may not be fully behind them.

Sarah: Let's close with what traders and long-term holders should be watching, and let's test our core thesis against everything we've covered.

Mike: On guidance and forward indicators, the filing points to several things worth monitoring. The December eleventh, twenty twenty-six deadline for the continuing resolution is the most immediate catalyst. If Congress passes full-year twenty twenty-seven appropriations at or near the administration's one point five trillion dollar request, that is a significant unlock for new program starts and contract awards. If the CR is extended again, new business is constrained. The multi-year contracts signed in twenty twenty-six for PAC-3 MSE, THAAD, PrSM, JATM, and F-35 sustainment are the backlog foundation — watch for any commentary on book-to-bill ratios in the full earnings call, because that tells you whether orders are outpacing deliveries. And watch the fixed-price contract book closely. Management has flagged the risk of additional losses. If another quarter produces five hundred million or more in unfavorable adjustments, the margin compression story becomes a margin deterioration story.

Sarah: What would prove our thesis wrong?

Mike: Two things specifically. First, if the unfavorable profit adjustments on the F-16, C-130, Heavy Lift, and Seahawk programs stabilize or reverse in the fourth quarter — meaning management has successfully re-estimated those contracts and the losses are behind them — then the margin compression concern diminishes significantly, and the revenue growth story becomes much cleaner. Second, if Congress passes full-year twenty twenty-seven appropriations at or near the historic one point five trillion dollar request before the end of the first quarter of twenty twenty-seven, the budget uncertainty risk evaporates and the new program start pipeline opens. Either of those outcomes would weaken the cautionary elements of our thesis considerably.

Sarah: And the thesis itself — does the full weight of evidence confirm it?

Mike: It confirms the core claim and adds nuance. Lockheed is executing a genuine production surge, revenue is growing at eleven percent, new long-cycle contracts are being signed, and the budget environment is historically favorable. That is the mid-cycle expansion thesis confirmed. But the fixed-price contract losses — nearly five hundred sixty-five million dollars in unfavorable adjustments in a single quarter — are a real and present drag that prevents this from being a clean expansion story. The company is growing into a larger revenue base while simultaneously absorbing execution costs on legacy fixed-price work. From a valuation framing standpoint, at current operating margins, this equity is priced like a defense prime executing a clean ramp, not one absorbing half a billion dollars in quarterly contract charges. That gap between perception and execution reality is the central tension investors should hold in mind.

Sarah: If you want to stay ahead of filings like this one — same week, grounded in the actual document — follow the show. You will not need to wait for the analyst consensus to catch up.

Mike: A reminder that nothing in this episode constitutes investment advice. All figures and statements are drawn directly from Lockheed Martin's ten-Q filing for the quarter ended September twenty-seventh, twenty twenty-six. Do your own diligence before making any financial decisions.

Sarah: For Aviation Intelligence Weekly, I'm Sarah.

Mike: And I'm Mike. We'll see you next week.

How this brief was checked

Before any audio was produced, this script was checked claim by claim against the source filing and market data: 58 claims checked, 49 verified against source data, 0 critical issues and 9 minor issues found on 2026-11-06.

JetExpat is an AI-generated publication with an automated verification step and a human approval gate. That process has limits, and we set them out plainly — see how it works. Always verify against the original filing before acting on a number.